320 related articles for article (PubMed ID: 30451739)
1. Future Trends in Demand for Liver Transplant: Birth Cohort Effects Among Patients With NASH and HCC.
Shingina A; DeWitt PE; Dodge JL; Biggins SW; Gralla J; Sprague D; Bambha K
Transplantation; 2019 Jan; 103(1):140-148. PubMed ID: 30451739
[TBL] [Abstract][Full Text] [Related]
2. Projected future increase in aging hepatitis C virus-infected liver transplant candidates: a potential effect of hepatocellular carcinoma.
Biggins SW; Bambha KM; Terrault NA; Inadomi J; Shiboski S; Dodge JL; Gralla J; Rosen HR; Roberts JP
Liver Transpl; 2012 Dec; 18(12):1471-8. PubMed ID: 23008049
[TBL] [Abstract][Full Text] [Related]
3. NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances.
Noureddin M; Vipani A; Bresee C; Todo T; Kim IK; Alkhouri N; Setiawan VW; Tran T; Ayoub WS; Lu SC; Klein AS; Sundaram V; Nissen NN
Am J Gastroenterol; 2018 Nov; 113(11):1649-1659. PubMed ID: 29880964
[TBL] [Abstract][Full Text] [Related]
4. Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.
Young K; Aguilar M; Gish R; Younossi Z; Saab S; Bhuket T; Liu B; Ahmed A; Wong RJ
Liver Transpl; 2016 Oct; 22(10):1356-66. PubMed ID: 27348270
[TBL] [Abstract][Full Text] [Related]
5. Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.
Cholankeril G; Wong RJ; Hu M; Perumpail RB; Yoo ER; Puri P; Younossi ZM; Harrison SA; Ahmed A
Dig Dis Sci; 2017 Oct; 62(10):2915-2922. PubMed ID: 28744836
[TBL] [Abstract][Full Text] [Related]
6. High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation.
Kern B; Feurstein B; Fritz J; Fabritius C; Sucher R; Graziadei I; Bale R; Tilg H; Zoller H; Newsome P; Eschertzhuber S; Margreiter R; Öfner D; Schneeberger S
Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):205-210. PubMed ID: 30320609
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma.
Lewin SM; Mehta N; Kelley RK; Roberts JP; Yao FY; Brandman D
Liver Transpl; 2017 Aug; 23(8):1015-1022. PubMed ID: 28340509
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.
Wong RJ; Cheung R; Ahmed A
Hepatology; 2014 Jun; 59(6):2188-95. PubMed ID: 24375711
[TBL] [Abstract][Full Text] [Related]
9. Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation.
Goldberg D; Ditah IC; Saeian K; Lalehzari M; Aronsohn A; Gorospe EC; Charlton M
Gastroenterology; 2017 Apr; 152(5):1090-1099.e1. PubMed ID: 28088461
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic Steatohepatitis Becomes the Leading Indication for Liver Transplant Registrants Among US Adults Born Between 1945 and 1965.
Shirazi F; Wang J; Wong RJ
J Clin Exp Hepatol; 2020; 10(1):30-36. PubMed ID: 32025164
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States.
Younossi ZM; Stepanova M; Ong J; Trimble G; AlQahtani S; Younossi I; Ahmed A; Racila A; Henry L
Clin Gastroenterol Hepatol; 2021 Mar; 19(3):580-589.e5. PubMed ID: 32531342
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.
Wong RJ; Aguilar M; Cheung R; Perumpail RB; Harrison SA; Younossi ZM; Ahmed A
Gastroenterology; 2015 Mar; 148(3):547-55. PubMed ID: 25461851
[TBL] [Abstract][Full Text] [Related]
13. Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.
Castelló B; Aguilera V; Blázquez MT; Rubín Á; García M; Vinaixa C; Benlloch S; SanJuan F; Montalva E; López R; Berenguer M
Ann Hepatol; 2019; 18(6):855-861. PubMed ID: 31543468
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States.
Yang JD; Larson JJ; Watt KD; Allen AM; Wiesner RH; Gores GJ; Roberts LR; Heimbach JA; Leise MD
Clin Gastroenterol Hepatol; 2017 May; 15(5):767-775.e3. PubMed ID: 28013117
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.
Younossi Z; Stepanova M; Ong JP; Jacobson IM; Bugianesi E; Duseja A; Eguchi Y; Wong VW; Negro F; Yilmaz Y; Romero-Gomez M; George J; Ahmed A; Wong R; Younossi I; Ziayee M; Afendy A;
Clin Gastroenterol Hepatol; 2019 Mar; 17(4):748-755.e3. PubMed ID: 29908364
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience.
Perumpail RB; Wong RJ; Ahmed A; Harrison SA
Dig Dis Sci; 2015 Oct; 60(10):3142-8. PubMed ID: 26250831
[TBL] [Abstract][Full Text] [Related]
17. Portrait of Regional Trends in Liver Transplantation for Nonalcoholic Steatohepatitis in the United States.
Yuan L; Hanlon CL; Terrault N; Alqahtani S; Tamim H; Lai M; Saberi B
Am J Gastroenterol; 2022 Mar; 117(3):433-444. PubMed ID: 35083985
[TBL] [Abstract][Full Text] [Related]
18. Liver Transplantation for NASH-Related Hepatocellular Carcinoma Versus Non-NASH Etiologies of Hepatocellular Carcinoma.
Sadler EM; Mehta N; Bhat M; Ghanekar A; Greig PD; Grant DR; Yao F; Sapisochin G
Transplantation; 2018 Apr; 102(4):640-647. PubMed ID: 29319620
[TBL] [Abstract][Full Text] [Related]
19. Projected increase in obesity and non-alcoholic-steatohepatitis-related liver transplantation waitlist additions in the United States.
Parikh ND; Marrero WJ; Wang J; Steuer J; Tapper EB; Konerman M; Singal AG; Hutton DW; Byon E; Lavieri MS
Hepatology; 2019 Aug; 70(2):487-495. PubMed ID: 28833326
[TBL] [Abstract][Full Text] [Related]
20. Impact of obesity and diabetes on waitlist survival, probability of liver transplantation and post-transplant survival among chronic hepatitis C virus patients.
Aguilar M; Liu B; Holt EW; Bhuket T; Wong RJ
Liver Int; 2016 Aug; 36(8):1167-75. PubMed ID: 26858016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
